High cytoplasmic TRXR and TRX expression in patients with high-grade gliomas was associated with poor outcomes, whereas in medulloblastoma, high expression of cytoplasmic TRXR, TRX, and nuclear TRX was associated with worse prognosis [100]. This evidence concerns the gene TXN and glioma.